91 related articles for article (PubMed ID: 29278558)
1. Autopsy of an Elderly Man With Incidentally Diagnosed TDP-43 Proteinopathy.
Hata Y; Yoshida K; Nishida N
Alzheimer Dis Assoc Disord; 2018; 32(2):158-161. PubMed ID: 29278558
[No Abstract] [Full Text] [Related]
2. New terminology for a common TDP-43 proteinopathy.
Kurucu H; Spires-Jones T; Smith C
Lancet Neurol; 2019 Aug; 18(8):714-715. PubMed ID: 31202672
[No Abstract] [Full Text] [Related]
3. Prevalence of transactive response DNA-binding protein 43 (TDP-43) proteinopathy in cognitively normal older adults: systematic review and meta-analysis.
Nascimento C; Di Lorenzo Alho AT; Bazan Conceição Amaral C; Leite REP; Nitrini R; Jacob-Filho W; Pasqualucci CA; Hokkanen SRK; Hunter S; Keage H; Kovacs GG; Grinberg LT; Suemoto CK
Neuropathol Appl Neurobiol; 2018 Apr; 44(3):286-297. PubMed ID: 28793370
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 proteinopathy in familial motor neurone disease with TARDBP A315T mutation: a case report.
Cairns NJ; Perrin RJ; Schmidt RE; Gru A; Green KG; Carter D; Taylor-Reinwald L; Morris JC; Gitcho MA; Baloh RH
Neuropathol Appl Neurobiol; 2010 Dec; 36(7):673-9. PubMed ID: 20819167
[No Abstract] [Full Text] [Related]
5. An Autopsy-Proven Case of Limbic-Predominant Age-Related TDP-43 Encephalopathy.
Cho SH; Choi SM; Kim BC; Song WY; Kim HS; Lee KH
Yonsei Med J; 2020 Aug; 61(8):731-735. PubMed ID: 32734738
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels.
Nelson PT; Gal Z; Wang WX; Niedowicz DM; Artiushin SC; Wycoff S; Wei A; Jicha GA; Fardo DW
Neurobiol Dis; 2019 May; 125():67-76. PubMed ID: 30682540
[TBL] [Abstract][Full Text] [Related]
8. Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: effects of genetic, demographic and neuropathological variables.
Armstrong RA
Folia Neuropathol; 2016; 54(2):137-48. PubMed ID: 27543771
[TBL] [Abstract][Full Text] [Related]
9. Chronic Traumatic Encephalopathy Presenting as Alzheimer's Disease in a Retired Soccer Player.
Grinberg LT; Anghinah R; Nascimento CF; Amaro E; Leite RP; Martin Mda G; Naslavsky MS; Takada LT; Filho WJ; Pasqualucci CA; Nitrini R
J Alzheimers Dis; 2016 Jul; 54(1):169-74. PubMed ID: 27472879
[TBL] [Abstract][Full Text] [Related]
10. Could Lifetime Lead Exposure Play a Role in Limbic-predominant Age-related TDP-43 Encephalopathy (LATE)?
Fuller-Thomson E; Deng Z
J Alzheimers Dis; 2020; 73(2):455-459. PubMed ID: 31815698
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
Gao J; Wang L; Yan T; Perry G; Wang X
Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
[TBL] [Abstract][Full Text] [Related]
12. Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29.
Armon C; Miller RG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):97-8; author reply 98-100. PubMed ID: 21173609
[No Abstract] [Full Text] [Related]
13. Correspondence regarding: TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol 2010:69;918-29.
Bedlack RS; Genge A; Amato AA; Shaibani A; Jackson CE; Kissel JT; Wall C; King WM; Cupler E; Lou JS; Ensrud E; Tan E; Goldstein JM; Katz J; Dimachkie MM; Barohn RJ; Mozaffar T
J Neuropathol Exp Neurol; 2011 Jan; 70(1):96-7; author reply 98-100. PubMed ID: 21173608
[No Abstract] [Full Text] [Related]
14. Applause sign in clinically overlapping diseases: a case of TDP-43 proteinopathy.
Arkadir D; Greene PE; Waters CH; Moskowitz CB; Sharp ME
Parkinsonism Relat Disord; 2013 Aug; 19(8):774-5. PubMed ID: 23680421
[No Abstract] [Full Text] [Related]
15. TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN.
Rossor AM; Jaunmuktane Z; Rossor MN; Hoti G; Reilly MM
Neurology; 2019 Feb; 92(9):e951-e956. PubMed ID: 30700593
[TBL] [Abstract][Full Text] [Related]
16. Degenerator tau/TDP-43: rise of the machines.
Nestor PJ
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):945. PubMed ID: 23503648
[No Abstract] [Full Text] [Related]
17. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy.
Kawakami I; Arai T; Hasegawa M
Acta Neuropathol; 2019 Nov; 138(5):751-770. PubMed ID: 31555895
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of diffuse neurofibrillary tangles with calcification. With special reference to TDP-43 proteinopathy and alpha-synucleinopathy.
Habuchi C; Iritani S; Sekiguchi H; Torii Y; Ishihara R; Arai T; Hasegawa M; Tsuchiya K; Akiyama H; Shibayama H; Ozaki N
J Neurol Sci; 2011 Feb; 301(1-2):77-85. PubMed ID: 21106208
[TBL] [Abstract][Full Text] [Related]
19. [Neuropathology of TDP-43 proteinopathy].
Akiyama H; Hasegawa M
Brain Nerve; 2013 Dec; 65(12):1477-89. PubMed ID: 24323933
[TBL] [Abstract][Full Text] [Related]
20. Retrospective neuropathological diagnosis of TDP-43 proteinopathies: Factors affecting immunoreactivity of phosphorylated TDP-43 in fixed post-mortem brain tissue.
Robinson AC; Davidson YS; Minshull J; Lally I; Walker L; Mann DMA; Roncaroli F
Neuropathology; 2024 Apr; 44(2):173-179. PubMed ID: 37528690
[No Abstract] [Full Text] [Related]
[Next] [New Search]
